Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensinogen-deficient mice with hypotension

K Tanimoto1, F Sugiyama, Y Goto

  • 1Institute of Applied Biochemistry, University of Tsukuba, Ibaraki, Japan.

The Journal of Biological Chemistry
|December 16, 1994
PubMed
Summary

Mice lacking angiotensinogen, the precursor in the renin-angiotensin system, exhibit significantly lower blood pressure. This highlights the system's crucial role in regulating blood pressure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pressure Overload and Cardiac Remodelling-A Smoking Gun Points to Uncoupled Nitric Oxide Synthase: Oxidant Stress from Nitric Oxide Synthase-3 Uncoupling Stimulates Cardiac Pathologic Remodeling from Chronic Pressure Load. J Clin Invest 115: 1221-1231, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A.

Blood·2022
Same author

Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.

Oncogene·2017
Same author

Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.

Gene therapy·2014
Same author

The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus.

Cancer gene therapy·2013
Same author

Identification of two distinct Sp1- and RBF-1-like nuclear factors that bind to the upstream region of the human angiotensinogen promoter.

Endocrine·2010

Area of Science:

  • Biochemistry
  • Physiology
  • Genetics

Background:

  • The renin-angiotensin system (RAS) is a critical hormonal cascade regulating blood pressure and fluid balance.
  • Angiotensinogen is the precursor to angiotensin I, which is converted to the potent vasoconstrictor angiotensin II.
  • The role of angiotensinogen in maintaining blood pressure in vivo is not fully understood.

Purpose of the Study:

  • To investigate the physiological role of angiotensinogen in blood pressure regulation.
  • To generate and characterize angiotensinogen-deficient mice.

Main Methods:

  • Homologous recombination was used to create angiotensinogen-deficient mice.
  • Systolic blood pressure was measured in homozygous mutant and wild-type mice.

Related Experiment Videos

Main Results:

  • Angiotensinogen-deficient mice showed a complete absence of plasma angiotensin I.
  • Homozygous mutant mice exhibited significantly reduced systolic blood pressure (66.9 +/- 4.1 mm Hg) compared to wild-type controls (100.4 +/- 4.4 mm Hg).

Conclusions:

  • Angiotensinogen is essential for the production of angiotensin I and the overall function of the renin-angiotensin system.
  • The renin-angiotensin system plays an indispensable role in maintaining normal blood pressure.